CHAPTER 1
INTRODUCTION
This chapter presents the background of the study, statement of the problem, objectives
of the study, significance of the study, scope & limitations, and the terms used in the study.
Background of the Study
Studies conducted by Akinsulie and Idris (2024) have found that dengue fever virus
(DENV) is a mosquito-borne virus, mostly spread by Aedes aegypti. According to the World
Health Organization, DENV is found primarily in urban and semi-urban areas in tropical and
subtropical climates globally, putting approximately half of the world’s population at risk,
where about 100-400 million cases of the disease occur annually. In 2023 alone, there were
over five million cases of dengue fever reported in more than 80 countries and territories
worldwide. This is due to an ongoing outbreak of the disease potentiated by unanticipated spike
in cases. It is crucial to understand DENV transmission patterns to manage public health
effectively.
Additionally, according to Jaenisch et al. (2016) the burden of dengue continuous to
Increase globally, with an estimated 100 million clinically apparent infections occurring each
year. Although most dengue infections are asymptomatic, patients can present with a wide
spectrum of clinical symptoms ranging from mild febrile illness through to severe
manifestations of bleeding, organ impairment, and hypovolaemic shock due to a systematic
vascular leak syndrome. Clinical diagnosis of dengue and identification of which patients are
likely to develop severe disease remain challenging.
The purpose of this qualitative study is to investigate symptoms of dengue fever and
suggest possible solutions on how can we deal with it, to analyze the factors influencing the
emotional responses of dengue patients and the subsequent coping strategies they employ
following diagnosis, to identify factors influencing patient perceptions of treatment
effectiveness and actual treatment outcomes.
Statement of the Problem
This study aims to investigate the experiences of dengue patients regarding their possessed
physical symptoms, emotional reactions and coping mechanisms throughout their journey, from
diagnosis to recovery. Specifically, this paper will seek to answer the following:
1. What are the experiences of dengue patients regarding their perceived physical
symptoms, emotional reactions and coping mechanism during their journey?
2. How does the initial diagnosis of dengue fever impact patients emotional
responses and subsequent coping strategies?
3. What are the perceptions of dengue patients regarding the effectiveness of the
treatment they received?
Objectives of the Study
• To explore the personal experiences of dengue patients in their physical and
emotional aspects throughout their journey.
• To determine the coping strategies employed by patients following their
diagnosis and how these strategies, vary based on initial emotional responses.
• To determine the perceptions of dengue patients with the treatment received.
Significance of the Study
To the Dengue Patients. This study provides insights into the emotional and psychological
aspects of living with dengue, helping patients understand that their experience are shared. It
can empower them with coping strategies and foster a sense of community and support during
their recovery journey.
To the Hospitals. Findings can inform hospital practices and patient care protocols by
highlighting the importance of addressing not only the physical but also the emotional needs of
dengue patients. This can lead to improved patient satisfaction and better health outcomes.
To the Healthcare Facilities. The study emphasizes the need for comprehensive care
approaches that incorporate mental health support for dengue patients. It can guide healthcare
facilities in developing programs and resources that enhance patient education and emotional
well-being.
To the Future Researchers. This research lays the groundwork for further studies on the lived
experiences of dengue patients, encouraging exploration of related topics such as long-term
psychological effects and the effectiveness of various coping strategies. It can also inspire
comparative studies with other infectious diseases.
Scope and Limitation
This study is a qualitative research. Its main purpose is to investigate the experiences of dengue
patients regarding their possessed physical symptoms, emotional reactions and coping
mechanisms throughout their journey, from diagnosis to recovery.
The scope of this qualitative study focuses on lived experiences of dengue patients, specifically
examining their physical symptoms, emotional reactions, and coping mechanisms from the
moment of diagnosis through their recovery process. By utilizing in depth interviews and
personal narratives, the research aims to capture the multifaceted experiences of patients,
providing insights into how they navigate the challenges posed by the disease. This study to
highlight the interplay between physical health and emotional well-being, shedding light on the
support system and coping strategies employed by patients. However, the limitation of this
research include a potentially small and non-representative sample size, which may restrict the
generalizability of the findings. Furthermore, the study may not account for variations in
healthcare access or socio-economic factors that could influence patients experiences, thereby
narrowing the contextual understanding of dengue’s impact on diverse population.
This study will not go further beyond what it seek to explore and will not ask questions
or discuss anything more personal to participants.
Definition of Terms
To understand better the contents of the study, he following terms were operationally defined.
Coping Mechanism. strategies used to cope-up, adopt and accept the situation.
Diagnosis. the time when the patient already know that they have dengue.
Emotional Reaction. responses that occur in mind that affects body when encountering
something that affects emotionally
Physical Symptoms. observable or measurable signs that indicates a health condition or illness
Recovery. a return to a normal state of health, mind or strength.
CHAPTER 2
REVIEW OF RELATED LITERATURE AND STUDIES
This includes the review of related literature and studies which the researchers have to shed
light the topic under study.
Review Of Related Literature
FOREIGN
In a literature review, Niyati K. et al. (2016) found that dengue fever is a major global
health problem, spreading rapidly over the past 50 years. It’s found in 128 countries, mostly in
developing nations, threatening nearly 4 billion people yearly. Studies estimate 390 million
dengue infections annually, with 96 million confirmed cases. It’s spread by Aedes mosquitoes,
mainly in tropical and subtropical areas, risking infection for about a third of the world’s
population. Dengue causes various illnesses, from mild fever to severe, sometimes fatal,
hemorrhagic fever. Its spread is linked to urbanization, travel, poor mosquito control, and
globalization. While there’s no cure, a vaccine is now licensed in some countries. Aedes
mosquitoes, primarily Ae. Aegypti, spread dengue; others like Ae. Albopictus also transmit it.
The mosquito life cycle takes about 8-10 days.
There is an urgent need to identify correlates of both vaccine protection and disease
enhancement (Wilde-Smith et al., 2018). Mortality from severe dengue is low, but the economic
and resource burden on health services remains substantial in endemic settings. Unfortunately,
progress towards development of effective therapeutics has been slow, despite notable advances
in the understanding of disease pathogenesis and considerable investment in antiviral drug
discovery. For decades antibody-dependent enhancement has been the prevalent model to
explain dengue pathogenesis, but it was only recently demonstrated in vivo and in clinical
studies. At present, the current mainstay of management for most symptomatic dengue patients
remains careful observation and prompt but judicious use of intravenous hydration therapy for
those with substantial vascular leakage.
Armed Forces medical services (Undurrraga, E.A et al., 2015). The Mexican Ministry
of Health (MoH) establishes national guidelines for the 32 state health departments, while daily
operations remain the responsibility of state and local health services. Federal-level vector
control and dengue surveillance guidelines, developed by the MoH, involve collaboration with
the 32 state health services and organizations such as IMSS, ISSSTE, PEMEX and the Armed
Forces medical services. A public health laboratory network diagnoses a sample of suspected
dengue patients—all probable cases in areas without recent dengue or during low transmission,
and approximately 30% during transmission or outbreaks—using confirmatory assays (NS1,
IgM, or IgG ELISA). A subset (10%) of positive samples undergoes virus isolation analysis.
Weekly reporting is mandated for probable and confirmed dengue cases, while probable or
confirmed dengue hemorrhagic fever (DHF) cases and dengue-related deaths require 24-hour
reporting. The MoH estimates dengue cases in two phases: first, multiplying probable cases
by the positive case proportion from the lab-diagnosed sample (yielding possible cases), and
then adding the total lab-confirmed cases.
Local
Dengvaxia, a chimeric yellow fever tetravalent dengue vaccine developed by
SanofiPasteur is widely licensed in dengue-endemic countries. In a large cohort study
Dengvaxia was found to partially protect children who had prior dengue virus (DENV)
infections but sensitized seronegative children to breakthrough DENV disease of enhanced
severity. In 2019, the European Medicines Agency and the US FDA issued licenses that
reconciled safety issues by restricting vaccine to individuals with prior dengue infections.
Haltstead et al., (2020) proposed recommendations concerning continued use of this dengue
vaccine.(1) obtain a better definition of vaccine efficacy and safety through enhanced phase 4
surveillance, (2) obtain a valid, accessible, sensitive, specific and affordable serological test
that identifies past wild-type dengue virus infection and (3) clarify safety and efficacy of
Dengvaxia in flavivirus immunes. In the absence of an acceptable serological screening test
these unresolved ethical issues suggest Dengvaxia be given only to those signing informed
consent.
While prior research has illuminated the seasonal genetic structure and expansion of
*Aedes aegypti* mosquito vectors, and the connectivity among populations across various
island seaports [28, 29], understanding of genetic structuring within highly urbanized, dengue-
endemic regions remains limited (Carvajal, T.M et al., 2020). This study focuses on
Metropolitan Manila, a location ideal for investigating the influence of urbanization on the
current genetic structure of *Ae. Aegypti*. Previous research in this area has primarily
examined the relationship between dengue epidemiology and climate [5, 30, 31], or employed
wing geometric morphometrics to analyze population structure [32], providing insufficient
information regarding genetic structure and relatedness. To address this gap, the study collected
adult *Ae. Aegypti* samples from multiple sites within Metropolitan Manila to characterize
the population genetic structure and inter-population relationships.
Review Of Related Studies
FOREIGN
The outpatient study revealed that the highest levels of depression and stress were
observed immediately following dengue infection. A Pakistani study reported high anxiety and
depression levels in 60% of hospitalized dengue patients, with a correlation to symptom
severity [10]. The researchers suggest that the lower depression scores in the outpatient study
may be due to the later assessment timing, after the acute phase of the illness had passed
(Buenaño et al., 2024). The study compared the mental health and certain cognitive functions
of individuals with dengue (IgM-positive) and healthy controls during the 2021 dengue
outbreak in Esmeraldas, Ecuador.
The World Health Organization (WHO) identified dengue fever as a top ten global
health threat in 2019. A significant portion of the world’s population—an estimated 3.9 billion
people, or 40-50%—are at risk of infection, with 128 countries facing dengue risk, and 70% of
the global burden concentrated in Asia (Brady et al., unspecified). A global outbreak was
marked by a surge in reported dengue cases, rising from under 0.5 million in 2000 to over 3.34
million in 2016. Although global case numbers declined in 2017, a substantial increase to 4.3
million cases occurred in 2019. That year, the highest numbers of cases were reported in Brazil,
the Philippines, Vietnam, Mexico, Nicaragua, Malaysia, and India, with Sri Lanka ranking
eighth globally and fifth in Asia (Jaywickreme, K.P et al., 2021). Sri Lanka experienced a major
dengue epidemic in 2017 (186,101 cases, >320 deaths), the largest in three decades. Despite
control measures, cases resurged in 2019, reaching 102,746—double the 2018 total—
concentrated primarily in the western province, with 20% in Colombo (Jaywickreme, K.P et
al., 2021). While dengue deaths increased from 58 in 2018 to 90 in 2019, the mortality rate per
case decreased. Dengue fever mortality is generally below 1%, while dengue hemorrhagic
fever mortality ranges from 2-5% with prompt treatment but can reach 20% if left untreated.
LOCAL
Comparing DENV genetic material from both mosquitoes and people could improve
our understanding of how different dengue viruses are related (Saito et al., 2020). Most studies
only focus on people who have symptoms, ignoring those without symptoms, who are
increasingly important in the spread of dengue. A previous study showed that people without
symptoms can still infect mosquitoes, even with lower virus levels in their blood [24],
suggesting they might act as hidden sources of infection for mosquitoes [25,26], spreading the
virus. Therefore, dengue surveillance needs methods that consider these undetected infections.
Mosquito-based viral testing can help find these asymptomatic infections [15]. A one-month
study in Tarlac City, Philippines, during the 2015 dengue peak season examined mosquitoes
collected near homes of people suspected of having dengue to determine the different types of
dengue viruses in the local mosquito population.
Studies conducted by Ylade et al., (2021) have found that a single dose of CYD-TDV
(Dengvaxia, Sanofi Pasteur) given to nine to fourteen-year-old children through a community-
based mass vaccination program conferred protection against dengue with warning signs and
severe dengue but were unable to conclude on protection against milder illness. These studies
emphasize the importance of prevention through vaccination.
Dengue fever diagnosis relies on both clinical symptoms and blood tests, such as NS1
tests, for confirmation. The timing of testing is critical, as the virus may persist for several days
after infection. Patients may experience a critical period, typically between days five and seven,
where their condition could deteriorate. Treatment options vary depending on the severity of
the illness, ranging from home care for mild cases to hospitalization for more severe cases. The
involvement of family members in the patient’s care is often beneficial. Dengue poses
significant health risks, including internal bleeding and the potential for severe dehydration,
necessitating careful fluid management. While blood transfusions may be necessary in some
instances, they are not a routine treatment for all dengue patients. continues to inform best
practices for diagnosis and treatment. (Dr. Lee S. et al., 2015)
References:
(Wilder-Smith et al., 2018)
[Link]
hl=en&as_sdt=0,5#d=gs_qabs&t=1737877708809&u=%23p%3DHxGRVmJcW7YJ
(Saito et al., 2020)
[Link]
Aedes_aegypti_mosquitoes_collected_concurrently_with_suspected_patients_in_Tarlac_
City_Philippines
(Niyati K. et al., 2016)
[Link]
engue+patients+in+other+countries+&btnG=#d=gs_qabs&t=1737630794916&u=%23p
%3DJYVri0-k6j4J
(Carvajal, T.M et al., 2020)
[Link]
+fever&qst=br#d=gs_qabs&t=1738107119650&u=%23p%3DeBwygPOuw3UJ
(Ylade et al., 2021)
[Link]
eness+of+treatment+of+dengue+in+the+Philippines+&btnG=#d=gs_qabs&t=173787965
1267&u=%23p%3D_jh1KeGDSSAJ
(Haltstead et al., 2020)
[Link]
eness+of+treatment+of+dengue+in+the+Philippines+&btnG=#d=gs_qabs&t=173787971
1622&u=%23p%3DfXee5Yme5YMJ
(Buenaño et al., 2024)
[Link]
(Jaywickreme, K.P et al., 2021)
[Link]
+fever&qst=br#d=gs_qabs&t=1737970052004&u=%23p%3DeBwygPOuw3UJ
(Undurraga, E.A et al., 2015)
[Link]
hl=tl&as_sdt=0,5#d=gs_qabs&t=1737969323572&u=%23p%3DXwLPUoUbh5QJ
(Dr. Lee S. et al.,)
[Link]
CHAPTER 3
RESEARCH METHODOLOGY
This chapter explains methodologies that were used in gathering data and analysis which are
relevant to the research. The methodologies will include areas such as research design,
respondents of the study, locale of the study, data gathering procedure, data gathering
method/instrument and data analysis.
Research Design
The researchers will use phenomenological research design as the study is attempting
to know the lived experiences of dengue patients. In the context of investigating the dengue
patients, this approach seeks to explore the subjective experiences of patients from the moment
of diagnosis through their recovery. Specifically, a semi-structured interview with open-ended
questions will be conducted so that the researchers can ask additional questions during the
interviews if clarifications and further explanations will be needed.
Respondents of the Study
The respondents of the study will be consisted of 15 participants in Gerona, Tarlac
(researcher’s community).
Participant selection employed a non-probability sampling incorporating purposive
sampling and snowball sampling. Purposive sampling was strategically used to select
participants possessing specific characteristics relevant to the research questions, such as
particular demographics, experiences, or knowledge. This targeted approach enriched the data
by focusing on individuals who could provide valuable insights related to the study’s objectives.
Snowball sampling expanded the sample by leveraging the networks of initially recruited
participants. Participants were asked to refer other individuals who met the inclusion criteria,
facilitating access to a wider range of perspectives and experiences within the community.
The researchers believe that these participants would be enough to provide sufficient
and essential information to answer the questions raised in this society.
Locale of the Study
The study will be conducted in the researcher’s community, Gerona, Tarlac.
Data Gathering Procedure
A consent form will be given to each of them before the interview and will serve as a
document providing that they have given their permission for them to be interviewed by the
researchers. After the consent from have been signed by the respondents, the interviewer will
inform them when the interview proper starts and so as the recording.
When all the respondents have already been interviewed, the recorded answers will be
transcribed into texts for analyzation.
Since this study is descriptive in nature, the use of a semi-structured interview will
allow the researchers some flexibility in the way they worded the questions for each individual
respondent. It will also give the researchers the opportunity to probe for more information and
clarification when necessary. The researchers need to have a skill to match the interview
questions to an appropriate techniques (Neuman, 2000)
Data Gathering Instrument
In conducting the interview, the researchers will be writing down notes of the
respondents’ answers. The researchers will also use smartphones as their audio/video recording
material in order to be accurately documenting the answers in the interview to avoid
misinterpretation.
Data Analysis
When the answers of the respondents have already been transcribed into texts, which
was referred by Mthembu (2000) as raw data that need to be converted into refined data for
better analysis by the researcher, these would be translated into English as part of data
refinement. The refined data will be analyzed using thematic analysis. Braun and Clarke (2006)
state that thematic analysis is a foundational method of analysis that needed to be defined and
described to solidify its place in qualitative research. It is a method for identifying, analyzing,
organizing, describing, and reporting themes found within a data set (Braun & Clarke, 2006).
The respondents' answers to each questions will be evaluated Into codes and these
codes will be simplified into categories, and from the categories, the researchers will generate
a theme which will represent the answer that prevailed for each questions raised in this study.